Coronavirus disease 2019 (COVID-19) is a highly heterogeneous disease regarding
severity, vulnerability to infection due to comorbidities, and treatment approaches. The …

Abstract Purpose Coronavirus disease-19 (COVID-19) has spread throughout the world. It
was initially defined as a potentially severe syndrome affecting the respiratory tract, but it has …

Abstract Purpose Glucocorticoids (GCs), alone or associated to other drugs, were widely
used in the management of patients affected by severe acute respiratory syndrome caused …

Patients with endogenous or exogenous glucocorticoid (GC) excess exhibit a range of side
effects, including an increased risk of infections. Via both mechanism, immune impairments …

The coronavirus disease 2019 (COVID-19) is an emerging pandemic challenge. Acute
respiratory distress syndrome (ARDS) in COVID-19 is characterized by a severe cytokine …

The coronavirus disease 2019 (COVID-19) pandemic is currently one of the major health
concerns worldwide accounting for many deaths and posing a great social and economic …

The current Coronavirus disease outbreak requires that physicians work in collaboration
with other physicians especially in intensive care and emergency units. To fight against this …

Objective To study the adrenocortical response to an acute coronavirus disease-2019
(COVID-19) infection. Methods Morning plasma cortisol, adrenocorticotropic hormone …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), first identified in
December 2019, causes coronavirus disease 2019 (COVID-19). It is reasonable to presume …

In critically ill patients affected by severe acute respiratory syndrome caused by Sars-Cov-2
infection, steroids, usually methylprednisolone, are currently administered despite data on …